Two years ago, July 2012, I purchased two up and coming pharma company stocks. I bought Horizon Pharma (HZNP) at $7.00 and Catalyst Pharma (CPRX) at .65. A year later I sold HZNP at a loss ($2.50) and sold CPRX at a loss as well ($.50). Oh well, that's how it goes - right? Now I realize anything can happen in this crazy stock market, but if I would have waited just one more year, the results would have been a lot different. A good friend of mine told me not to sell these two stocks, but out of fear of losing even more of my investment, I sold them both - sound familiar?. Well, today HZNP is valued at $15.43 (who would have known) and CPRX is valued at $2.46. My point is this, we all want SCRC to be a $1 to $2 stock. I believe if we just give Mr. Scheiderman the time to implement his business plan, SCRC will perform just like HZNP and CPRX has. A year ago I sold two stocks worth holding on to, I'm not going to sell SCRC because it is DEFINITELY worth holding on to. Success takes time and patience and I have both.

Don't sweat this sideways trading going on right now. We all know the potential SCRC has and the revenues being generated. I sold Glaxo way too soon, HZNP and CPRX too soon, and I learned my lesson. SCRC is demonstrating strength in the market place and will be a dominate powerhouse in the compounding pharmacy arena, and yes in the China OTC market as well. The wait will be worth all of our investment. GO SCRC!!!